title: Re: Slowly activating potassium conductance (I(D)): a potential target for stroke therapy.
authors.forename: Jean Michel
authors.initials: JM
authors.lastname: Achard
authors.forename: Oliver
authors.initials: O
authors.lastname: Godefroy
authors.forename: Michel
authors.initials: M
authors.lastname: Andrejak
authors.forename: Hakim
authors.initials: H
authors.lastname: Mazouz
authors.forename: Albert
authors.initials: A
authors.lastname: Fournier
authors.forename: Leonardo
authors.initials: L
authors.lastname: Fernandez
mesh_terms: D000804:Angiotensin II / Q000378:metabolism* / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000503:physiopathology; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011918:Rats, Inbred SHR; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D020521:Stroke / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D018690:Excitatory Amino Acid Agonists; D015221:Potassium Channels; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000804:Angiotensin II